Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

SIGA Technologies Inc. - Common Stock (NQ:SIGA)

5.955 +0.115 (+1.97%)
Streaming Delayed Price Updated: 3:19 PM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about SIGA Technologies Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Stay updated with the stocks that are on the move in today's after-hours session.
The regular session of the US market on Monday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
Japan Approves SIGA Technologies Antiviral As First For Smallpox, Mpox
Japan approves SIGA's TEPOXX for smallpox, mpox, and cowpox, expanding antiviral availability for orthopoxviruses with proven safety and efficacy. 
Via Benzinga
Arm Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket
Shares of Rumble Inc. 
Via Benzinga
SIGA Stock Earnings: SIGA Technologies Reported Results for Q1 2024
SIGA Technologies just reported results for the first quarter of 2024. 
Via InvestorPlace
Earnings Scheduled For May 8, 2025
Via Benzinga
3 Stocks Upping Dividends & 1 With A 10% Special Dividend Yield
Via MarketBeat
NIH Trial Finds Tecovirimat Ineffective As Monotherapy For Mpox
SIGA Technologies’ (NASDAQ:SIGA) antiviral drug tecovirimat, when used without other treatments, did not reduce the time for clade ... 
Via Benzinga
Earnings Scheduled For March 11, 2025
Via Benzinga
WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped'
To fight the mpox outbreak in Africa, the World Health Organization calls for funding help for its six-month plan. 
Via Benzinga
Government Contract Win May Improve Investor Sentiment For SIGA Tech After Disappointing Trial Data: Analyst
SIGA Technologies secures a $9 million DoD contract for TPOXX, boosting total outstanding orders to $154 million. Recent BARDA and DoD wins reinforce growth despite challenges in a key mpox trial. 
Via Benzinga
Immunome Stock Sees RS Rating Jump To 91
Immunome stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 88 to 91. 
Via Investor's Business Daily
PTC Therapeutics Stock Earns RS Rating Upgrade To 83
The Relative Strength (RS) Rating for PTC Therapeutics stock climbed into a new percentile Monday, with a rise from 80 to 83. 
Via Investor's Business Daily
3 Promising Vaccine Stocks To Watch In The Event Of A Mpox Surge
Mpox rerun is making these stocks soar. But a non-vaccine approach could yield greater gains. 
Via Talk Markets
Mpox Variant Sparks Global Concern As Europe, China Ramp Up Screening
Increased screening for deadly new version of mpox is seen in Europe and China. More imported cases are expected. New vaccines are being developed. 
Via Benzinga
Stock Of The Day: Bull Trap Snares SIGA Technologies On Heels Of Mpox Study
Shares of SIGA Technologies (SIGA) had a 'bull trap' on Wednesday. There may be another one today. This can mean the stock is headed lower. 
Via Benzinga
H&R Block Posts Upbeat Earnings, Joins Alibaba Group, CI&T And Other Big Stocks Moving Higher On Friday
Via Benzinga
Crude Oil Gains Over 1%; Alibaba Posts Weak Revenue
Via Benzinga
Exposures Fossil Fuels
Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On?
Several healthcare stocks associated with mpox are seeing increased attention Thursday after the World Health Organization declared a public health emergency in response to an mpox outbreak in Africa. 
Via Benzinga
Russell 2000 Set For Strongest Session In A Month As US Economy Defies Recession Fears: Small Cap Movers On Thursday
Russell 2000 ETF (ARCA: IWM) up 2.7%, its strongest session in a month, driven by positive economic data & increased consumer spending, boosting confidence in US economy. 
Via Benzinga
Topics ETFs Economy
Exposures Economy
Nasdaq Jumps Over 2%; Walmart Earnings Top Views
Via Benzinga
Dow Surges Over 500 Points; US Retail Sales Rise In July
Via Benzinga
Topics Stocks
Exposures US Equities
In NIH-Cosponsored Monkeypox Virus Study In Congo, SIGA Technologies' Antiviral Tecovirimat Did Not Improve Lesion Resolution, Stock Tanks
"NIH's NIAID reveals results from the PALM 007 trial of SIGA Technologies' Tpoxx for monkeypox (mpox) treatment. The study missed its primary endpoint but showed potential benefits in early and severe... 
Via Benzinga
WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak
A public health emergency for mpox in Africa saw vaccine stocks jump Wednesday. A look at the stocks and what's next for fighting the virus. 
Via Benzinga
GeoVax, SIGA Technologies Shares Soar After WHO Declares Mpox A Global Health Emergency
Shares of GeoVax Labs and SIGA Technologies are surging Wednesday amid Mpox Emergency Declaration. Here's what you need to know. 
Via Benzinga
Patterson Companies, KB Home And Other Stocks To Watch This Tuesday
Via Benzinga
Why Calidi Biotherapeutics is Moving Higher Monday
Calidi and SIGA are partnering in order to advance Calidi's RTNova virotherapy for lung cancer and metastatic solid tumors. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.